References

Lymphangioleiomyomatosis.
Taveira-DaSilva AM, Steagall WK, Moss J.
Cancer Control 2006, 13: 276-85.
The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.
Ryu JH, Moss J, Beck GJ, Lee JC, Brown KK, Chapman JT, Finlay GA, Olson EJ, Ruoss SJ, Maurer JR, Raffin TA, Peavy HH, McCarthy K, Taveira-Dasilva A, McCormack FX, Avila NA, Decastro RM, Jacobs SS, Stylianou M, Fanburg BL; NHLBI LAM Registry Group.
Am J Respir Crit Care Med. 2006 Jan 1;173(1):105-11.
Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: role for tumor suppressor TSC2.
Goncharova EA, Goncharov DA, Spaits M, Noonan DJ, Talovskaya E, Eszterhas A, Krymskaya VP.
Am J Respir Cell Mol Biol 2006;34:561–72.
Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis.
Seyama K, Kumasaka T, Souma S, Sato T, Kurihara M, Mitani K, Tominaga S, Fukuchi Y.
Lymphat Res Bio 2006, 4: 143-52.
Modulation of Cell Migration and Invasiveness by Tumor Suppressor TSC2 in Lymphangioleiomyomatosis.
Goncharova EA, Goncharov DA, Lim PN, Noonan D, and Krymskaya VP.
Am J Respir Cell Mol Biol 2006, 34: 473–480.
Lymphangiogenesismediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis.
Kumasaka T, Seyama K, Mitani K, Souma S, Kashiwagi S, Hebisawa A, Sato T, Kubo H, Gomi K, Shibuya K.
Am J Surg Pathol 2005;29: 1356–1366.
Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis.
Crooks DM, Pacheco-Rodriguez G, DeCastro RM, McCoy JP, Wang JrJA, Kumaki F, Darling T, and Moss J.
Proc. Natl. Acad. Sci. USA 2004, 101: 17462–17467.
Lymphangiogenesis in lymphangioleiomyomatosis.
Kumasaka T, Seyama K, Mitani K, Sato T, Souma S, Kondo T, Hayashi S, Minami M, Uekusa T, Fukuchi Y, Suda K.
Am J Surg Pathol 2004, 28: 1007-16.
Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism.
Karbowniczek M, Astrinidis A, Balsara BR, Testa JR, Lium JH, Colby TV, McCormack FX, Henske EP.
Am J Respir Crit Care Med 2003, 167:976 –982.
Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score.
Matsui K, Beasley MB, Nelson WK, Barnes PM, Bechtle J, Falk R, Ferrans VJ, Moss J, Travis WD.
Am J Surg Pathol. 2001 Apr;25(4):479-84.
High frequency of pulmonary Lymphangioleiomyomatosis in women with tuberous sclerosis complex.
Costello LC, Hartman TE, Ryu JH.
Mayo Clin Proc 2000, 75: 591–594.
Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.
Carsillo T, Astrinidis A, Henske EP.
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6085-90.